Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation
Journal of Orthopaedic Research · 2024
DOI: 10.1002/jor.25762 ↗At a glance
Journal article in Journal of Orthopaedic Research, 2024. Written by Hsiang-Ning Chang and 6 co-authors. Institution: Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan. Major MEDLINE topics: Achilles Tendon, Actins, Lidocaine, Tenocytes. Cited 1 times so far (Crossref); 33 references. Funded by: Chang Gung Memorial Hospital, Linkou, Taiwan, Chang Gung Memorial Hospital, Linkou.
Abstract (original language)
Lidocaine is the most frequently applied local infiltration anesthetic agent for treating tendinopathies. However, studies have discovered lidocaine to negatively affect tendon healing. In the current study, the molecular mechanisms and effects of lidocaine on tenocyte migration were evaluated. We treated tenocytes intrinsic to the Achilles tendons of Sprague–Dawley rats with lidocaine. The migration ability of cells was analyzed using electric cell‐substrate impedance sensing (ECIS) and scratch wound assay. We then used a microscope to evaluate the cell spread. We assessed filamentous actin (F‐actin) cytoskeleton formation through immunofluorescence staining. In addition, we used Western blot analysis to analyze the expression of phospho‐focal adhesion kinase (FAK), FAK, phospho‐paxillin, paxillin, and F‐actin. We discovered that lidocaine had an inhibitory effect on the migration of tenocytes in the scratch wound assay and on the ECIS chip. Lidocaine treatment suppressed cell spreading and changed the cell morphology and F‐actin distribution. Lidocaine reduced F‐actin formation in the tenocyte during cell spreading; furthermore, it inhibited phospho‐FAK, F‐actin, and phospho‐paxillin expression in the tenocytes. Our study revealed that lidocaine inhibits the spread and migration of tenocytes. The molecular mechanism potentially underlying this effect is downregulation of F‐actin, phospho‐FAK, and phospho‐paxillin expression when cells are treated with lidocaine.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan.
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Taoyuan, Taoyuan City, Taiwan.
- Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan City, Taiwan.
- Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital at Keelung, Keelung City, Taiwan.
- School of Medicine, Chang Gung University, Taoyuan City, Taiwan.
- Center of Comprehensive Sports Medicine, Chang Gung Memorial Hospital at Taoyuan, Taoyuan City, Taiwan.
ORCID profiles: Tung-Yang Yu, Chih-Chin Hsu, Li-Ping Lin
Funding
- Chang Gung Memorial Hospital, Linkou, Taiwan
- Chang Gung Memorial Hospital, Linkou
Cite
APA
Chang, H. N., Chen, C. K., Yu, T. Y., Pang, J. S., Hsu, C. C., Lin, L. P., & Tsai, W. C. (2024). Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25762
Vancouver
Chang HN, Chen CK, Yu TY, Pang JS, Hsu CC, Lin LP, et al. Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation. Journal of Orthopaedic Research. 2024. doi:10.1002/jor.25762
BibTeX
@article{Chang2024,
author = {Chang, Hsiang-Ning and Chen, Chih-Kuang and Yu, Tung-Yang and Pang, Jong-Hwei S and Hsu, Chih-Chin and Lin, Li-Ping and Tsai, Wen-Chung},
title = {Lidocaine inhibits migration of tenocytes by downregulating focal adhesion kinase and paxillin phosphorylation},
journal = {Journal of Orthopaedic Research},
year = {2024},
doi = {10.1002/jor.25762}
}
EUVIMED